90. Kongreß pp 1327-1365 | Cite as

Postersession II

Nephrologie 2
  • H. E. Feucht
  • R. Wank
  • G. J. O’Neill
  • E. Held
  • G. Riethmüller
  • D. J. Schendel
  • D. Klingmüller
  • A. Neumark
  • S. Schmidt
  • H. J. Kramer
  • C. Wanner
  • H. Neumann
  • W. H. Boesken
  • P. Schollmeyer
  • R. Rohrbach
  • M. Weber
  • H. Köhler
  • W. Thoenes
  • K.-H. Meyer zum Büschenfelde
  • C. Spieker
  • H. Zumkley
  • K. Kisters
  • N. v. Husen
  • J. Lohmann
  • H. P. Bertram
  • A. E. Lison
  • H. G. Fromme
  • A. Seidler
  • H. C. Schuppe
  • H. B. Steinhauer
  • J. Bommer
  • H. P. Geisen
  • C. von Sonntag
  • N. Büchler
  • E. Ritz
  • G. Sold
  • K. W. Rumpf
  • A. T. Trompler
  • B. Schünemann
  • F. Scheler
  • H. Kreuzer
  • D. Heinrich
  • M. Wiedemann
  • G. Müller-Berghaus
  • R. Windeck
  • H.-D. Jakubowski
  • H. Wilms
  • C.-M. Sczesny
  • R. Lang
  • J. Michels
  • R. Grundmann
  • W. Kaufmann
  • H. Machnik
  • E. Schulz
  • W. G. Wood
  • J. Wilhelm
  • K. Sack
  • R. M. Lederle
  • D. Klaus
  • R. Kluthe
  • E. Calarasu
  • M. Förster
  • H. Haase
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE, volume 90)

Zusammenfassung

Der Einfluß immungenetischer Faktoren auf Entstehung und Progredienz von primären Glomerulonephritiden (GN) ist weitgehend ungeklärt. Die HLA-Region ist das zentrale „Kontrollorgan“ für die Immunantwort des Menschen [2]. Deshalb wurde inzwischen in mehreren Studien eine mögliche Assoziation bestimmter HLA-Allele mit verschiedenen Formen von primärer GN untersucht (Übersichtsarbeit [4]). Der generelle Nachteil solcher Untersuchungen liegt in der relativen Häufigkeit vieler HLA-Antigene in der Normalbevölkerung, wodurch die Aussagekraft für das Patientenkollektiv oftmals unbefriedigend ist. Es schien uns daher sinnvoll nach weiteren möglichst präzisen immungenetischen Markern zu fahnden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Awdeh ZL, Alper CA (1980) Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 77: 3576–3580PubMedCrossRefGoogle Scholar
  2. 2.
    Bach FH, van Rood JJ (1976) The major histocompatibility complexgenetics and biology. N Engl J Med 295: 806–813PubMedCrossRefGoogle Scholar
  3. 3.
    O’Neill GJ, Yang SY, Dupont B (1978) Two HLA–linked loci controlling the fourth component of human complement. Proc Natl Acad Sci USA. 75: 5154–5169Google Scholar
  4. 4.
    Rashid HU, Papiha SS, Agroyannis B, Morely AR, Ward MK, Roberts DF, Kerr DNS (1983) The associations of HLA and other genetic markers with glomerulonephritis. Hum Genet 63: 38–44PubMedCrossRefGoogle Scholar
  5. 5.
    Terasaki PI, McClelland LP (1964) Microdroplet assay of human serum cytotoxins. Nature 204: 998–1000PubMedCrossRefGoogle Scholar
  6. 1.
    Arendshorst WJ, Finn WF, Gottschalk CW (1975) Pathogenesis of acute renal failure following temporary renal ischemia in the rat. Circ Res 37: 558–568PubMedCrossRefGoogle Scholar
  7. 2.
    Burke TJ, Arnold PE. Grossfeld RW, Schrier RW (1982) Effect of calcium membrane inhibition on norepinephrine–induced acute renal failure. In: Eliahou HE (ed) Acute renal failure. J Libbey, London, pp 239–240Google Scholar
  8. 3.
    Chan L, Ledingham JGG. Dixon JA, Thulborn KR, Waterton JC, Radda GK, Ross BD (1982) Acute renal failure: a proposed mechanism based upon 31P nuclear magnetic resonance. In: Eliahou HE (ed) Acute renal failure. J Libbey, London, pp 35–41Google Scholar
  9. Epstein FH, Balaban RS. Ross BD (1982) Mitochondrial anoxia in intact perfused kidney. In: Eliahou HE (ed) Acute renal failure. J Libbey, London, p 297Google Scholar
  10. 5.
    Gerlach E, Deuticke B, Dreisbach RH, Rosarius CW (1963) Zum Verhalten von Nucleotiden and ihren dephosphorylierten Abbauprodukten in der Niere bei Ischämie and kurzzeitiger postischämischer Wiederdurchblutung. Pflügers Arch 278: 296–315CrossRefGoogle Scholar
  11. 6.
    Minuth AN, Terell JB jr, Suki WN (1976) Acute renal failure: a study of the course and prognosis of 104 patients and the role of furosemid. Am J Med Sci 271: 317–324PubMedCrossRefGoogle Scholar
  12. 7.
    Smolens P, Stein JH (1981) Pathophysiology of acute renal failure. Am J Med 70: 479–482PubMedCrossRefGoogle Scholar
  13. 8.
    Wilson DR, Arnold PE, Burke TJ, Schrier RW (1984) Mitochondria] calcium accumulation and respiration in ischemic acute renal failure in the rat. Kidney Int 25: 519–526PubMedCrossRefGoogle Scholar
  14. 1.
    Schreiner GE (1963) The nephrotic syndrome. In: Strauss/Welt (eds) Disease of the kidney. Little, Brown & Co, Boston, p 335Google Scholar
  15. 2.
    Scribner BH, Goldstein HH, Rifkin H (1974) in discussion: the problem of end stage nephropathy. Kidney Int 6: S21 — S26Google Scholar
  16. 3.
    Kussman MJ, Goldstein HH, Gleason RE (1976) The clinical course of diabetic nephropathy. JAMA 236: 1861–1863PubMedCrossRefGoogle Scholar
  17. 4.
    Warms PC, Rosenbaum BJ, Michelis MF, Haas JE (1973) Idiopathic membranous glomerulonephritis occurring with diabetes mellitus. Arch Intern Med 132: 725–738CrossRefGoogle Scholar
  18. 5.
    Murphy WM, Deodhar SD, McCormack LJ, Osborne DG (1973) Immunopathologic studies in glomerular diseases with membranous lesions. Am J Clin Pathol 60: 364–376PubMedGoogle Scholar
  19. 6.
    Sharma HM, Yum MN, Kleit S (1974) Acute glomerulonephritis with diabetes mellitus. Arch Pathol 97: 152–154PubMedGoogle Scholar
  20. 7.
    Olivero J, Suki WN (1977) Acute glomerulonephritis complicating diabetic nephropathy. Arch Intern Med 137: 732–734PubMedCrossRefGoogle Scholar
  21. 8.
    Wass JAH, Watkins PJ, Dische EF, Parsons V (1978) Renal failure, glomerular disease and diabetes mellitus. Nephron 21: 289–296PubMedCrossRefGoogle Scholar
  22. 9.
    Rao KV, Crosson JT (1980) Idiopathic membranous glomerulonephritis in diabetic patients. Arch Intern Med 140: 624–627CrossRefGoogle Scholar
  23. 10.
    Kasinath BS, Mujais SK, Spargo BH, Katz AJ (1983) Nondiabetic renal disease in patients with diabetes mellitus. Am J Med 75: 613–617PubMedCrossRefGoogle Scholar
  24. 11.
    McCrary RF, Pitts TO, Puschett JB (1981) Diabetic nephropathy: natural cours, survivorship and therapy. Am J Nephrol 1: 206–218PubMedCrossRefGoogle Scholar
  25. 12.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T, Sasdelli M, Locatelli F (1984) Controlled trial of methylprednisolon and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 310: 946–950PubMedCrossRefGoogle Scholar
  26. 13.
    Watkins PJ, Blainey JD, Brewer DB, Fitzgerald MG, Malins JM, O’Sullivan DJ, Pinto JA (1972) The natural history of diabetic renal disease. A follow–up study of a series of renal biopsies. Q J Med 41: 437–456Google Scholar
  27. 14.
    Goto Y (1978) Vascular complications in diabetes in Japan. Adv Metab Disord 9: 167–200PubMedGoogle Scholar
  28. 15.
    Acharya VN, Chawla KP (1978) Diabetic nephropathy a review. J Postgr Med 24: 138–146Google Scholar
  29. 1.
    Ben–Bassat M, Boner G, Rosenfeld J, Pick AI, Kahana M, Hazaz B, Hochman B (1983) The clinicopathologic features of cryoglobulinemicnephropathy. Am J Clin Pathol 79: 147–156Google Scholar
  30. 2.
    Brouet J–C, Clauvel J–P, Danon F, Klein M, Seligmann M (1974) Biological and clinical significance of cryoglobulins Am J Med 57: 775–788Google Scholar
  31. 3.
    De Vecchi A, Montagnino G, Pozzi C, Tarantino A, Locatelli F, Ponticelli C (1983) Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy. Clin Nephrol 19: 221–227PubMedGoogle Scholar
  32. 4.
    Franklin EC (1980) Cryoproteins. In: Parker CW (ed) Clinical immunology, Vol 1. Saunders, Philadelphia London Toronto, p 534Google Scholar
  33. 5.
    Gamble CN, Ruggles SW (1978) The immunopathogenesis of glomerulonephritis associated with mixed cryoglobulinemia. N Engl J Med 299: 81–85PubMedCrossRefGoogle Scholar
  34. 6.
    Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC (1980) Mixed cryoglobulinemia: clinical aspects and long term follow–up of 40 patients. Am J Med 69: 287–308PubMedCrossRefGoogle Scholar
  35. 7.
    Grey HM, Köhler PF (1973) Cryoimmunoglobulins. Sem in Hematol 10: 87–112Google Scholar
  36. 8.
    Matuhasi T, Usui M, Mizuno N (1968) yA–yG–mixed cryoglobulin. Jpn J Exp Med 38: 205–211Google Scholar
  37. 9.
    Mookerjee BK, Maddison PJ, Reichlin M (1978) Mesangial IgA–IgG deposition in mixed cryoglobulinemia. Am J Med Sci 276: 221–225PubMedCrossRefGoogle Scholar
  38. 10.
    Shumak KH, Rock GA (1984) Therapeutic plasma exchange. N Engl J Med 310: 762–771PubMedCrossRefGoogle Scholar
  39. 11.
    Takeda K, Okumura H, Hirose S, Muranaka M (1974) Immuno–and physicochemical studies of an IgA–IgG mixed cryoglobulin. Int Arch Allergy 46: 38–52PubMedCrossRefGoogle Scholar
  40. 12.
    Wagner O, Mustakallio KK, Räsänen JA (1968) Mixed IgA–IgG cryoglobulinemia. Am J Med 44: 179–187CrossRefGoogle Scholar
  41. 13.
    Whitsed HM, Penny R (1971) IgA/IgG cryoglobulinemia with vasculitis. Clin Exp Immunol 9: 183–191PubMedGoogle Scholar
  42. 14.
    Zollinger HU, Mihatsch MJ (1978) Renal pathology in biopsy. Springer, Berlin Heidelberg New York, p 169CrossRefGoogle Scholar
  43. 1.
    Ackrill P, Ralston HJ, Day JP, Hodge KC (1980) Successful removal of aluminium from patients with dialysis encephalopathy. Lancet 2: 692–693PubMedCrossRefGoogle Scholar
  44. 2.
    Alfrey AC, Mishell JB, Burks J, Contiguglia SR, Rudolph H, Lewin E, Holmes JH (1972) Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs 18: 257–261PubMedCrossRefGoogle Scholar
  45. 3.
    Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy syndrome. N Engl J Med 294: 184–188PubMedCrossRefGoogle Scholar
  46. 4.
    Cornells R (1982) Variability in reported plasma AI–concentrations. Int. Workshop on: The role of biological monitoring in the prevention of aluminium toxicity in man. Commission of the European Communities, Luxembourg, 5–7 July, 1982Google Scholar
  47. 5.
    Elliot HL, MacDougall AT (1978) Aluminium studies in dialysis encephalopathy. Proc Eur Dial Transplant Assoc 15: 157Google Scholar
  48. 6.
    Zumkley H, Knoll O, Graefe U, Bertram HP (1983) Klinik der Dialyse–Encephalopathie (im Druck )Google Scholar
  49. 1.
    Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW (1981) Kidney Int 19: 593–602PubMedCrossRefGoogle Scholar
  50. 2.
    Boesken WH, Mamier A, Ziupa J (1983) Abstr 5th Europ Congr Clin Chem, p 149Google Scholar
  51. 3.
    Diskin CJ, Ho G (1981) Rhode Island Med J 64: 521–525Google Scholar
  52. 4.
    Felgenhauer K, Ackermann R, Schliep G (1980) J Neurol Sci 47: 21–34PubMedCrossRefGoogle Scholar
  53. 5.
    Mancini G, Carbonara AO, Heremans JF (1965) Immunochemistry 2: 235–254PubMedCrossRefGoogle Scholar
  54. 6.
    Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski Z, Pyle WK (1978) Ann Intern Med 88: 449–456PubMedCrossRefGoogle Scholar
  55. 7.
    Rubin J, McFarland S, Hellems EW, Bower JD (1981) Kidney Int 19: 460–464PubMedCrossRefGoogle Scholar
  56. 8.
    Steinhauer HB, Hertting G (1981) Eur J Pharmacol 69: 199–203 — 9. Wardle EN (1973) Br Med J 2: 518Google Scholar
  57. 10.
    Yatzidis H (1977) Clin Chem 23: 811–812PubMedGoogle Scholar
  58. 1.
    Ono K, Tatsukawa R, Wakimoto T (1975) Migration of plasticizer from hemodialysis blood tubing. JAMA 234: 141–145CrossRefGoogle Scholar
  59. 2.
    Gibson ThP, Briggs WA, Boone BJ (1976) Delivery of di–2–ethylhexyl phthalate to patients during hemodialysis. J Lab Clin Med 87: 519–524PubMedGoogle Scholar
  60. 3.
    Bommer J, Ritz E, Andrassy K (1984) Effects secondaires des materiels utilises en hémodialyse. Actual Néphrol (in press)Google Scholar
  61. 4.
    Ljunggren (1984) Plasticizer migration from blood lines in hemodialysis. Int J Artif Org 8: 99–102CrossRefGoogle Scholar
  62. 5.
    Jacobson MS, Kevy SV, Grand RJ (1977) Effects of plasticizer leached from polyvinyl chloride on the subhuman primate: a consequence of chronic transfusion therapy. J Lab Clin Med 89: 1066PubMedGoogle Scholar
  63. 6.
    Jacobson MS, Kevy SV, Parkman R, Wesolowski JS (1980) An in vitro evaluation of a new plasticizer for polyvinylchloride medical devices. Transfusion 20: 443–447PubMedCrossRefGoogle Scholar
  64. 7.
    Patterson R, Roberts M, Zeiss RC, Pruzansky JJ (1981) Human antibodies against trimellity proteins: comparison of sepcificities of IgG, IgA and IgE classes. Int Arch Allergy Appl Immunol 66: 332–340Google Scholar
  65. 1.
    Baldamus CA, Ernst W, Lysaght MJ, Shaldon S, Koch KM (1983) Hemodynamics in hemofiltration. Int J Artif Org 6: 27–31Google Scholar
  66. 2.
    Elcayamu U, Gardin JM, Berkley R, Houghes CA, Henry WL (1983) The use of Doppler flow velocity measurement to assess the hemodynamic response to vasodilators in patients with heart failure. Circulation 67: 377–381CrossRefGoogle Scholar
  67. 3.
    Huntsman LL, Stewart DK, Barnes SR, Franklin SB, Colocousis JS, Hessel EA (1983) Noninvasive Doppler determination of cardiac output in man. Clinical validation. Circulation 67: 593–602Google Scholar
  68. 4.
    Quellhorst I, Schünemann B, Hildebrandt U, Falda Z (1980) Response of the vascular system to different modifications of hemofiltration and hemodialysis. Proc EDTA 17: 197–204Google Scholar
  69. 5.
    Trompler AT, Sold G, Vogt A, Kreuzer H (1984) Nichtinvasive Messung des Herzzeitvolumens mit quantitativer Doppler–Echokradiographie. Z Kardiol (Suppl l) 73: 37Google Scholar
  70. 6.
    Valdes–Cruz LM, Sahn DJ (1982) Two dimensional echo Doppler for non–invasive quantitation of cardiac flow: a status report. Mod Concepts Cardiovasc Dis 51: 123–128Google Scholar
  71. 1.
    Rosenbaum J, Winsten S, Kramer MS, Moros J, Raja R (1970) Resin hemoperfusion in the treatment of drug intoxication. Trans Am Soc Artif Intern Organs 16: 134PubMedGoogle Scholar
  72. 2.
    Heath A, Delin K, Eden E, Martensson E, Selander D, Wickström J, Ahlem J (1980) Hemoperfusion with amberlite resin in the treatment of selfpoisoning. Acta Med Scand 207: 455PubMedCrossRefGoogle Scholar
  73. 3.
    Ludlam CA, Bolton AE, Moore S, Cash JD (1975) New rapid method for diagnosis of deep venous thrombosis. Lancet 2: 259–260PubMedCrossRefGoogle Scholar
  74. 1.
    European Multicenter Trial (1982) Cyclosporin A as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Lancet 2: 57–60Google Scholar
  75. 2.
    Foegh ML, Winchester JF, Zmudka M, Helferich GB, Cooly C, Ramwell PW, Schreiner GE (1981) Urine i–TXB2 in renal allograft rejection. Lancet 2: 431–434PubMedCrossRefGoogle Scholar
  76. 3.
    Hemmingsen L, Jensen H, Skaarup P (1976) The urinary excretion of ten plasma proteins in long–term transplant patients. Acta Med Scand 199: 311–316PubMedCrossRefGoogle Scholar
  77. 4.
    Klintmalm GMG, Iwatsuki S, Starzl TE (1981) Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet 1: 470–471PubMedCrossRefGoogle Scholar
  78. 5.
    Steinhauer HB, Lubrich I, Giinter B, Schollmeyer P (1983) Response of human platelets to inhibition of thromboxane synthesis. Clin Hemorheol 3: 1–12Google Scholar
  79. 6.
    Steinhauer HB, Wilms H, Sczesny C–M, Schollmeyer P (1984) Thromboxane B2 as marker of renal allograft rejection. Platelets Prostaglandins and the Cardiovascular System, Florence, February 8–11, Abstract C32Google Scholar
  80. 7.
    Uthmann U, Geisen HP, Dreikorn K, Röhl L, Horsch R, Rössler W (1980) Diagnostic and prognostic value of 132–microglobulin in renal transplantation. Transplant Clin Immunol 12: 259–265Google Scholar
  81. 8.
    Winchester JF, Gelfand MC, Foegh ML, Helferich GB, Schreiner GE (1983) Early indicators of renal allograft rejection. Kidney Int 23: S34 — S40Google Scholar
  82. 1.
    Cunnigham J, Vandenburg MJ, Holly IM, Goodwin FJ (1981) Impaired response of plasma renin activity to tilting after renal transplantation. Clin Sci 61: 69Google Scholar
  83. 2.
    Curtis J, Luke R, Dustan H, Kashgarian M, Wheelchei J, Jones P, Diethelm A (1983) Remission of essential hypertension after renal transplantation. N Engl J Med 309: 1009PubMedCrossRefGoogle Scholar
  84. 3.
    Brecht H, Ernst W, Koch K (1976) Plasma noradrenaline levels in regular haemodialysis patients. Proc Eur Dial Transplant Nephrol 12: 281Google Scholar
  85. 4.
    Diethelm A, Hartley M, Adrete J, Sterling W, Morgan J (1975) Treatment of accelerated hypertension and endstage renal failure by bilateral nephrectomy and renal transplantation. Surg Gynecol Obstet 140: 161PubMedGoogle Scholar
  86. 5.
    McGrath BP, Ledingham GG, Benedict CR (1978) Catecholamines in peripheral venous plasma in patients on chronic haemodialysis. Clin Sci Mol Med 55: 89PubMedGoogle Scholar
  87. 6.
    Smith R, Reid J, Warren D (1981) Adrenergic components of hypertension after renal transplantation. Clin Sci 61: 1875Google Scholar
  88. 1.
    Lüthgens M, Schlegel G (1980) CEA+TPA in der klinischen Tumordiagnostik, insbesondere des Mamma–Karzinoms. Tumor Diagnostik 2: 63–77Google Scholar
  89. 2.
    Björklund B (1980) On the nature and clinical use of tissue polypeptide antigen (TPA). Tumor Diagnostik 1: 9–20Google Scholar
  90. 3.
    Vorlaender KO (1983) Krebsdiagnostik durch immunologische Tumor–Marker. Diagnostik 16: 11–22Google Scholar
  91. 4.
    Vorlaender KO (1983) Tumordiagnostik unter Verwendung immunologischer Tumor–Marker. Wien Med Wochenschr 133: 59–66PubMedGoogle Scholar
  92. 5.
    von Kleist S (1983) Das karzinoembryonale Antigen (CEA). Schattauer, Stuttgart New York, S 33Google Scholar
  93. 1.
    Alatas H, Scharer K (1975) Wirkung von L–Histidin auf die Stickstoffbilanz bei Kindern mit chronischer Niereninsuffizienz. Nieren–Hochdruckkrankh 4: 67–71Google Scholar
  94. 2.
    Bergstrom J, Fürst P, Josephson B, Norée L–O (1972) Factors affecting in nitrogen balance in chronic uremic patients receiving essential amino acids intravenously or by mouth. In: Kluthe R, Berlyne G, Burton B (eds) Uremia. Thieme, StuttgartGoogle Scholar
  95. 3.
    Essers U (1982) In: Losse H, Renner E (Hrsg). Klinische Nephrologie, Bd I. Thieme, StuttgartGoogle Scholar
  96. 4.
    Giordano C, de Santo NG, Rinaldi S, de Pascale C, Pluvio M (1972) Histidine and glycine essential amino acids in uremia. In: Kluthe R, Berlyne G, Burton B (eds) Uremia. Thieme, StuttgartGoogle Scholar
  97. 5.
    Giordano C, de Santo NG, Rinaldi S, Acone D, Esposito R, Gallo B (1973) Histidine dupplements in the treatment of uremic anaemia. Proc. Xth Congr. EDTA 1973. Pitman Medical, vol X, p 160. BathGoogle Scholar
  98. 6.
    Jontofsohn R, Katz N, Stuber U, Kluthe R (1974) Einfluß von L–Histidin und Eisen auf die Anämie bei chronischer Niereninsuffizienz. Nieren–Hochdruckkrankh 3: 28–31Google Scholar
  99. 7.
    Lindenau K, Schmicker R, Cernacek P, Precht K, Spustova V, Dzurik R (1980) Indications for histidine substitution in RDT patients. In: Partsch G, Batsford S (eds) Histidine II. Thieme, StuttgartGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • H. E. Feucht
    • 1
  • R. Wank
    • 1
  • G. J. O’Neill
    • 1
  • E. Held
    • 1
  • G. Riethmüller
    • 1
  • D. J. Schendel
    • 1
  • D. Klingmüller
    • 2
  • A. Neumark
    • 2
  • S. Schmidt
    • 2
  • H. J. Kramer
    • 2
  • C. Wanner
    • 3
  • H. Neumann
    • 3
  • W. H. Boesken
    • 2
    • 7
  • P. Schollmeyer
    • 2
    • 6
    • 12
  • R. Rohrbach
    • 4
  • M. Weber
    • 5
  • H. Köhler
    • 5
  • W. Thoenes
    • 5
  • K.-H. Meyer zum Büschenfelde
    • 5
  • C. Spieker
    • 6
  • H. Zumkley
    • 6
  • K. Kisters
    • 6
  • N. v. Husen
    • 6
  • J. Lohmann
    • 6
  • H. P. Bertram
    • 6
  • A. E. Lison
    • 6
  • H. G. Fromme
    • 6
  • A. Seidler
    • 7
  • H. C. Schuppe
    • 7
  • H. B. Steinhauer
    • 6
    • 12
  • J. Bommer
    • 8
  • H. P. Geisen
    • 8
  • C. von Sonntag
    • 8
  • N. Büchler
    • 8
  • E. Ritz
    • 8
  • G. Sold
    • 9
  • K. W. Rumpf
    • 9
  • A. T. Trompler
    • 9
  • B. Schünemann
    • 9
  • F. Scheler
    • 9
  • H. Kreuzer
    • 9
  • D. Heinrich
    • 10
  • M. Wiedemann
    • 10
  • G. Müller-Berghaus
    • 10
  • R. Windeck
    • 11
  • H.-D. Jakubowski
    • 11
  • H. Wilms
    • 12
  • C.-M. Sczesny
    • 12
  • R. Lang
    • 13
  • J. Michels
    • 13
  • R. Grundmann
    • 13
  • W. Kaufmann
    • 13
  • H. Machnik
    • 14
  • E. Schulz
    • 14
  • W. G. Wood
    • 14
  • J. Wilhelm
    • 14
  • K. Sack
    • 14
  • R. M. Lederle
    • 15
  • D. Klaus
    • 15
  • R. Kluthe
    • 15
  • E. Calarasu
    • 15
  • M. Förster
    • 15
  • H. Haase
    • 15
  1. 1.Med. Klinik Innenstadt und Institut für ImmunologieUniversität MünchenDeutschland
  2. 2.Med. Univ.-PoliklinikBonnDeutschland
  3. 3.Med. Univ.-KlinikFreiburg/BrsgDeutschland
  4. 4.Patholog. InstitutFreiburg/BrsgDeutschland
  5. 5.I. Med. Klinik und Poliklinik und Pathologisch-Anatomisches InstitutJohannes-Gutenberg-UniversitätMainzDeutschland
  6. 6.Med. Univ.-Poliklinik MünsterDeutschland
  7. 7.Nephrolog. Abt., Med. KlinikAlbert-Ludwigs-UniversitätFreiburg/BrsgDeutschland
  8. 8.Univ.-Klinik HeidelbergMax-Planck-Institut für StrahlenchemieMülheim/RuhrDeutschland
  9. 9.Zentrum Innere MedizinGöttingenDeutschland
  10. 10.Zentrum für Innere Medizin und Klinische Forschungsgruppe für Blutgerinnung und Thrombose der Max-Planck Gesellschaft am KlinikumJustus-Liebig-UniversitätGießenDeutschland
  11. 11.Med. Klinik und Poliklinik und Abt. für allgemeine ChirurgieKlinikum Essen, GHSDeutschland
  12. 12.Med. Klinik, Abt. IV und ChirurgKlinik Universität FreiburgBrsgDeutschland
  13. 13.II. Med. Klinik und ChirurgKlinik Universität KölnDeutschland
  14. 14.Klinik für Innere MedizinMedizinischen Hochschule LübeckDeutschland
  15. 15.Med. Klinik I und Institut für Blutspendewesen der Städtischen Kliniken DortmundMed. Univ.-KlinikFreiburgBrsgDeutschland

Personalised recommendations